New Am Diabetes Assoc guidelines emphasize a more "personal" approach to setting goals for glycemic control

March 2009

New Am Diabetes Assoc guidelines emphasize a more "personal" approach to setting goals for glycemic control.

This is due to recent evidence that intensive treatment can lead to NO cardiovascular benefit or HIGHER mortality in some type 2s.

For most type 1s and 2s, the goal is still an A1c < 7%...or estimated average glucose (eAG) less than 154 mg/dL.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

12 issues every year, with brief articles about new meds and guidelines
48+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

greater scrutiny of propoxyphene (Darvocet, Darvon, etc)
Cardiology The metoprolol shortage will cause more questions on how to switch
Cardiology Is chlorthalidone better than hydrochlorothiazide
Bisphosphonates osteonecrosis of the jaw in patients taking bisphosphonates for osteoporosis
Gastroenterology new proton pump inhibitor called Kapidex
Diabetes New Am Diabetes Assoc guidelines emphasize a more "personal" approach to setting goals for glycemic control
Poison Prevention safety of topical camphor and menthol products (Vicks VapoRub, etc) in kids
Pediatrics whether oral corticosteroids are beneficial for wheezing in PRESCHOOLERS
Vaccines Parents continue to have fears about pediatric vaccines
Respiratory & Allergy new nasal spray for allergic rhinitis called Astepro
Fibromyalgia ads promoting Savella (milnacipran) as the first drug approved ONLY for fibromyalgia
new warnings about misusing topical anesthetics